The objective of this study is to evaluate the malabsorption blood test (MBT), stool
coefficient of fat absorption (CFA) and stool bomb calorimetry (BC) methods as potential
screening or diagnostic tests for reduced exocrine pancreatic function or pancreatic
insufficiency (RPF/PI). A further objective is to determine the test responses before and
after pancreatic enzyme medication administration (Creon36™) in the patients with chronic
pancreatitis (CP).
Phase:
Phase 2
Details
Lead Sponsor:
Children's Hospital of Philadelphia
Collaborators:
AbbVie National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NIDDK Sponsored Research Unit at the Phoenix Indian Medical Center Phoenix Indian Medical Center